A PriceWaterhouseCooper report trumpets the wonderful new combinations of health care companies combining to remake our health system. Hogwash.
Read More
A research letter in JAMA Internal Medicine discusses trends in Medicare spending for care at the end-of-life.
Read More
A study in Health Affairs looks at the potential value of one precision medicine.
Read More
Its not really shocking, but depressingly expected for drug companies to screw the public by preventing competition.
Read More
Another Milliman-related post, this time for their annual cost of health insurance report, which shows ongoing growth.
Read More
America's Health Insurance Plans release a study conducted by Milliman showing where commercial health insurance dollars go.
Read More
New "precision" medicines are being approved with fewer and small trials, which may raise safety questions.
Read More
A paper from the NBER discusses the lifetime out-of-pocket medical expenses households with persons over 70 face.
Read More
A brief from AHRQ summarizing research on mobile apps for diabetes management finds little value in improving health.
Read More
A study in Health Affairs finds small benefit from public health expenditures.
Read More
Today we look at a recent paper that once again correlates hospital market power and prices, a major cause of excessive health spending.
Read More
Today's price post discusses another KFF/Peterson work which analyzes prices and utilization across countries.
Read More
It is health care price week, and we start off with a Peterson/Kaiser Health System Tracker piece on price trends over the last few decades.
Read More
An organization called Consumers for Quality Care releases a survey of American's views on the health system.
Read More
Surescripts releases its annual report on the state of electronic transaction use in drug prescribing.
Read More